thyranon 100 mg chewable tablet - etsinnän tulokset

teva-liothyronine tablet

teva canada limited - liothyronine (liothyronine sodium) - tablet - 5mcg - liothyronine (liothyronine sodium) 5mcg - thyroid agents

Kanada - englanti - Health Canada

teva-liothyronine tablet

teva canada limited - liothyronine (liothyronine sodium) - tablet - 25mcg - liothyronine (liothyronine sodium) 25mcg - thyroid agents

Yhdysvallat - englanti - NLM (National Library of Medicine)

liothyronine sodium injection, solution

xgen pharmaceuticals djb, inc. - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 10 ug in 1 ml - liothyronine sodium injection (t 3 ) is indicated in the treatment of myxedema coma/precoma. liothyronine sodium injection (t 3 ) can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef. thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adrenal cortical insufficiency or untreated thyrotoxicosis. thyroid hormone preparations are also generally contraindicated in patients with hypersensitivity to any of the active or extraneous constituents of these preparations; however, there is no well-documented evidence in the literature of true allergic or idiosyncratic reactions to thyroid hormone. concomitant use of liothyronine sodium injection (t 3 ) and artificial rewarming of patients is contraindicated. (see precautions.)

Yhdysvallat - englanti - NLM (National Library of Medicine)

liothyronine sodium tablet

sigmapharm laboratories, llc - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 5 ug - liothyronine sodium tablets, usp are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. liothyronine sodium tablets, usp are indicated as an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer. liothyronine sodium tablets, usp are indicated as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy. limitations of use - liothyronine sodium tablets, usp are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with liothyronine sodium tablets, usp may induce hyperthyroidism [see warnings and precautions (5.4)]. - liothyronine sodium tablets, usp are not indicated for treatment of hypothyroidism during the recovery phase of s

Yhdysvallat - englanti - NLM (National Library of Medicine)

liothyronine sodium- liothyronine sodium tablet

paddock laboratories, llc - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 5 ug - thyroid hormone drugs are indicated: liothyronine sodium tablets, usp can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef. thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adrenal cortical insufficiency, untreated thyrotoxicosis and apparent hypersensitivity to any of their active or extraneous constituents. there is no well-documented evidence from the literature, however, of true allergic or idiosyncratic reactions to thyroid hormone.